观察胺碘酮注射液治疗急性心衰并快速心律失常的临床疗效
|
摘要
目的分析研讨胺碘酮注射液治疗急性心衰并快速心律失常的临床疗效。方法随机从我院2016年3月至2018年4月收治的急性心衰并快速心律失常患者中抽取80例做回顾分析,依据其治疗方式分组,其中40例接受常规抗心衰治疗(对照组),另40例接受胺碘酮注射液治疗(研究组),观察比较两组患者治疗效果。结果研究组总疗效(95.00%)高于对照组(72.50%),组间数据有统计学意义(P<0.05)。研究组不良反应总发生率(10.00%)虽略低于对照组(12.50%),但组间数据无统计学意义(P>0.05)。结论建议临床治疗急性心衰并快速心律失常,可考虑给予胺碘酮注射液,高效安全,利于疾病预后改善。
Objective To analyze the clinical efficacy of amiodarone injection in the treatment of acute heart failure with tachyarrhythmia. Methods Eighty patients with acute heart failure with tachyarrhythmia admitted to our hospital from March 2016 to April 2018 were randomLy selected for retrospective analysis. According to their treatment methods, they were divided into two groups: 40 patients received routine anti-heart failure treatment(control group) and 40 patients received amiodarone injection treatment(study group). The therapeutic effects of the two groups were observed and compared. Results The total efficacy of the study group was 95.00% higher than that of the control group(72.50%). The data between the groups were statistically significant(P<0.05). The total incidence of adverse reactions in the study group was 10.00%, although it was slightly lower than 12.50% in the control group, but the data between the groups was not statistically significant(P>0.05). Conclusion It is recommended to treat acute heart failure with tachyarrhythmia clinically. It can be considered to give amiodarone injection, which is efficient and safe, and is conducive to the improvement of disease prognosis.
Objective To analyze the clinical efficacy of amiodarone injection in the treatment of acute heart failure with tachyarrhythmia. Methods Eighty patients with acute heart failure with tachyarrhythmia admitted to our hospital from March 2016 to April 2018 were randomLy selected for retrospective analysis. According to their treatment methods, they were divided into two groups: 40 patients received routine anti-heart failure treatment(control group) and 40 patients received amiodarone injection treatment(study group). The therapeutic effects of the two groups were observed and compared. Results The total efficacy of the study group was 95.00% higher than that of the control group(72.50%). The data between the groups were statistically significant(P<0.05). The total incidence of adverse reactions in the study group was 10.00%, although it was slightly lower than 12.50% in the control group, but the data between the groups was not statistically significant(P>0.05). Conclusion It is recommended to treat acute heart failure with tachyarrhythmia clinically. It can be considered to give amiodarone injection, which is efficient and safe, and is conducive to the improvement of disease prognosis.
引文
[1]田鲜美,刘宇,王玫,等.参附注射液治疗急性心力衰竭(心气阳虚证)并快速性心律失常的临床观察[J].中国中医急症,2017,26(4):676-679.
[2]沈潞华.2014年急性心力衰竭诊断和治疗指南[J].中华临床医师杂志:电子版,2014,8(18):131-132.
[3]葛晓平,华崇俊,杨俊.胺碘酮联合琥珀酸美托洛尔缓释片治疗对快速心律失常患者血压和心率的影响[J].中国慢性病预防与控制,2017,25(6):463-465.
[4]许加素,彭晓琳,李洪林.葛根素注射液联合胺碘酮治疗冠心病患者PCI术后并发心律失常的疗效分析[J].中国药房,2016,27(36):5079-5081.
[5]杨洪亮.胺碘酮注射液治疗急性心衰合并快速心律失常效果观察[J].中国继续医学教育,2016,8(12):144-145.
[6]林青,刘宝宏,吴献豪,等.厄贝沙坦联合胺碘酮在心力衰竭合并心律失常患者中的治疗效果及对心功能的影响[J].中国循证心血管医学杂志,2017,9(6):732-733.
[7]沈绍清,任浩洋,康丽媛.盐酸胺碘酮相关急性肝、肾、心功能异常及电解质紊乱一例[J].海南医学,2015,26(9):1388-1391.
[8]罗玉钊,陈炎,何洪.胺碘酮治疗充血性心力衰竭合并室性心律失常的效果[J].中国医药导报,2015,12(8):57-60.
[9]李栋.芪苈强心胶囊联合胺碘酮治疗老年心力衰竭合并阵发性房颤疗效观察[J].西部中医药,2016,29(3):86-88.
[10]黎伟强.胺碘酮联合琥珀酸美托洛尔对慢性心力衰竭合并快室率心房颤动临床观察[J].中国循证心血管医学杂志,2016,8(2):189-191.
[2]沈潞华.2014年急性心力衰竭诊断和治疗指南[J].中华临床医师杂志:电子版,2014,8(18):131-132.
[3]葛晓平,华崇俊,杨俊.胺碘酮联合琥珀酸美托洛尔缓释片治疗对快速心律失常患者血压和心率的影响[J].中国慢性病预防与控制,2017,25(6):463-465.
[4]许加素,彭晓琳,李洪林.葛根素注射液联合胺碘酮治疗冠心病患者PCI术后并发心律失常的疗效分析[J].中国药房,2016,27(36):5079-5081.
[5]杨洪亮.胺碘酮注射液治疗急性心衰合并快速心律失常效果观察[J].中国继续医学教育,2016,8(12):144-145.
[6]林青,刘宝宏,吴献豪,等.厄贝沙坦联合胺碘酮在心力衰竭合并心律失常患者中的治疗效果及对心功能的影响[J].中国循证心血管医学杂志,2017,9(6):732-733.
[7]沈绍清,任浩洋,康丽媛.盐酸胺碘酮相关急性肝、肾、心功能异常及电解质紊乱一例[J].海南医学,2015,26(9):1388-1391.
[8]罗玉钊,陈炎,何洪.胺碘酮治疗充血性心力衰竭合并室性心律失常的效果[J].中国医药导报,2015,12(8):57-60.
[9]李栋.芪苈强心胶囊联合胺碘酮治疗老年心力衰竭合并阵发性房颤疗效观察[J].西部中医药,2016,29(3):86-88.
[10]黎伟强.胺碘酮联合琥珀酸美托洛尔对慢性心力衰竭合并快室率心房颤动临床观察[J].中国循证心血管医学杂志,2016,8(2):189-191.